These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27385173)

  • 1. The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.
    Hucke A; Ciarimboli G
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S157-72. PubMed ID: 27385173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saving ears and kidneys from cisplatin.
    Wensing KU; Ciarimboli G
    Anticancer Res; 2013 Oct; 33(10):4183-8. PubMed ID: 24122981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyspecific organic cation transporters and their biomedical relevance in kidney.
    Koepsell H
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):533-8. PubMed ID: 23852330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of organic cation transporters in drug-induced toxicity.
    Ciarimboli G
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):159-74. PubMed ID: 21241199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
    Yonezawa A; Inui K
    Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
    Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
    Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
    Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress in the organic cation transporters.
    Shu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):913-26. PubMed ID: 22086000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporters as a determinant of drug clearance and tissue distribution.
    Shitara Y; Horie T; Sugiyama Y
    Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic cation transporters are determinants of oxaliplatin cytotoxicity.
    Zhang S; Lovejoy KS; Shima JE; Lagpacan LL; Shu Y; Lapuk A; Chen Y; Komori T; Gray JW; Chen X; Lippard SJ; Giacomini KM
    Cancer Res; 2006 Sep; 66(17):8847-57. PubMed ID: 16951202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of
    Huang KM; Uddin ME; DiGiacomo D; Lustberg MB; Hu S; Sparreboom A
    Expert Opin Drug Metab Toxicol; 2020 Jun; 16(6):493-506. PubMed ID: 32276560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transporters in the distribution of platinum-based drugs.
    Harrach S; Ciarimboli G
    Front Pharmacol; 2015; 6():85. PubMed ID: 25964760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of organic cation transporters in drug-drug interaction.
    Koepsell H
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1619-33. PubMed ID: 26206523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.
    Jung N; Lehmann C; Rubbert A; Knispel M; Hartmann P; van Lunzen J; Stellbrink HJ; Faetkenheuer G; Taubert D
    Drug Metab Dispos; 2008 Aug; 36(8):1616-23. PubMed ID: 18490433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations.
    Hucke A; Park GY; Bauer OB; Beyer G; Köppen C; Zeeh D; Wehe CA; Sperling M; Schröter R; Kantauskaitè M; Hagos Y; Karst U; Lippard SJ; Ciarimboli G
    Front Chem; 2018; 6():180. PubMed ID: 29888219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of organic cations with a newly identified plasma membrane monoamine transporter.
    Engel K; Wang J
    Mol Pharmacol; 2005 Nov; 68(5):1397-407. PubMed ID: 16099839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane transporters as mediators of Cisplatin effects and side effects.
    Ciarimboli G
    Scientifica (Cairo); 2012; 2012():473829. PubMed ID: 24278698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane transporters as mediators of cisplatin side-effects.
    Ciarimboli G
    Anticancer Res; 2014 Jan; 34(1):547-50. PubMed ID: 24403515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
    Bachmakov I; Glaeser H; Fromm MF; König J
    Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.